Clinical outcomes in vitamin D treated and placebo patients
| Vitamin D group | Placebo group | ||||
| Baseline | 12 months | Baseline | 12 months | p Value | |
| EDSS (mean (SE)) | 2.0 (0.2) | 1.8 (0.2) | 1.5 (1.2) | 1.6 (1.3) | 0.071 |
| Change | −0.20 (0.1) | −0.02 (0.1) | |||
| ARR (mean (SE)) | 0.49 (0.5) | 0.26 (0.5) | 0.51 (0.5) | 0.28 (0.6) | NS |
| 95% CI | 0.31 to 0.66 | 0.08 to 0.44 | 0.33 to 0.70 | 0.07 to 0.49 | |
| TTW10 (mean (SE)) | 11.7 (1.1) | 9.7 (0.7) | 9.6 (1.0) | 11.2 (1.9) | 0.076 |
| Change | −2.44 (0.8) | 0.95 (1.1) | |||
| T25FW (mean (SE)) | 6.0 (0.9) | 5.3 (0.2) | 4.7 (1.4) | 5.1 (1.3) | 0.932 |
| Change | −0.62 (1.0) | 0.30 (0.9) | |||
ARR, annual relapse rate; Change, from baseline to 12 months; EDSS, Expanded Disability Status Scale; T25FW, timed 25 foot walk; TTW10, timed 10 foot tandem walk.